@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C1707310 "cascade"; ns1:C2986546 "target"; ns1:C4761546 "cascade" . rdf:predicate ns3:TRIPLE_UID:pq34mfzt-TRIPLE-ABSTRACT-1 "appear" . rdf:subject ns1:C0011777 "dexamethasone"; ns1:C0178602 "dose"; ns1:C0205251 "low"; ns1:C0869039 "dose"; ns1:C1550472 "low"; ns1:C1611820 "low"; ns1:C1619811 "low"; ns1:C2700150 "low"; ns1:C3890211 "low"; ns1:C4048187 "low"; ns1:C4321351 "low"; ns1:C4522223 "low"; ns1:C5203106 "low" . rdfs:Triple-UID ns2:TRIPLE_UID:pq34mfzt-TRIPLE-ABSTRACT-1 "pq34mfzt-TRIPLE-ABSTRACT-1" . rdfs:sentence rdfs:label "To target the inflammatory cascade, low-dose dexamethasone appears to be helpful in moderate to severe cases and trials with anti-interleukin agents (e.g., tocilizumab, anakinra, siltuximab) and non-steroidal anti-inflammatory drugs are showing early promising results." . rdfs:triple rdfs:label "low - dose dexamethasone appears To target the inflammatory cascade" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:22.302221"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "dLVEHjVyHqyOMVgKY84J1Ug73nDwZY2WU+N+Sn9vntLLV1Lk5IGlxkcwv6bduR010NvuSR8Yl6L1EkLxylji9TQpTlr/aNUSXllK5U4pCN6sVHe433JIU4EKyLgOk2cSblQLa0zN9+MA9j5CJ1NRN9z2IRqmQBrHv8cvnm7bI9k="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:22.302221"^^xsd:dateTime; prov:wasAttributedTo . }